Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor | UniteRare Disease Library

Overview

Also known as:

Acute myeloid leukemia AML AML and myelodysplastic syndromes related to topoisomerase type 2 inhibitor MDS Myelodysplastic syndromes

Orphanet ↗NORD ↗

Treatments

2 available

Synribo

omacetaxine mepesuccinate· IVAX International GmbHOrphan DrugAccelerated Approval

Treatment of adult patients with chronic or accelerated phase chronic myeloid leukemia (CML) with resistance and/or intolerance to two or more tyrosine kinase inhibitors (TKI)

View Details →

Imatinib Mesylate

IMATINIB MESYLATE· Apotex Corp

Patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy

View Details →FDA Label ↗

Clinical Trials

View all trials with filters →

No actively recruiting trials found for Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor community →

Specialists

View all specialists →

No specialists are currently listed for Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers

🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitorForum →

No community posts yet. Be the first to share your experience with Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor.

Start the conversation →

Latest news about Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor

2 articles

Clinical trialUNITERAREApr 5, 2026

New Recruiting Trial: Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

Researchers are testing a new drug called pacritinib in people ages 12 and older who have myelodysplastic syndromes or myelodysplastic/myeloproliferative neopla…

Clinical trialUNITERAREApr 3, 2026

New Recruiting Trial: A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

Researchers are testing a new drug called elritercept to see if it works better than a standard treatment (epoetin alfa) for anemia in adults with myelodysplast…

See all news about Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor →

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor

What treatment and support options exist for Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor?

1 patient support program are currently tracked on UniteRare for Acute myeloid leukemia and myelodysplastic syndromes related to topoisomerase type 2 inhibitor. See the treatments and support programs sections for copay assistance, eligibility, and contact details.